000 01824 a2200517 4500
005 20250517063754.0
264 0 _c20160923
008 201609s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/s12885-015-1929-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoehler, Bruno Christian
245 0 0 _aPan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.
_h[electronic resource]
260 _bBMC cancer
_cNov 2015
300 _a919 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aAutophagy
_xdrug effects
650 0 4 _aBiphenyl Compounds
_xpharmacology
650 0 4 _aCell Culture Techniques
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHT29 Cells
650 0 4 _aHumans
650 0 4 _aIndoles
650 0 4 _aNitrophenols
_xpharmacology
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xgenetics
650 0 4 _aPyrroles
_xpharmacology
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aSulfonamides
_xpharmacology
700 1 _aJassowicz, Adam
700 1 _aScherr, Anna-Lena
700 1 _aLorenz, Stephan
700 1 _aRadhakrishnan, Praveen
700 1 _aKautz, Nicole
700 1 _aElssner, Christin
700 1 _aWeiss, Johanna
700 1 _aJaeger, Dirk
700 1 _aSchneider, Martin
700 1 _aSchulze-Bergkamen, Henning
773 0 _tBMC cancer
_gvol. 15
_gp. 919
856 4 0 _uhttps://doi.org/10.1186/s12885-015-1929-y
_zAvailable from publisher's website
999 _c25464810
_d25464810